Angiogenesis 2024: Interim findings of phase 2 RIPPLE-1 trial on intravitreal dexamethasone implant for DMO and RVO
Dr Baruch Kuppermann discusses interim results from the first in-human Phase 2 RIPPLE-1 Trial of a dexamethasone implant for diabetic macular oedema and retinal vein occlusion.
Voyager study provides data on real-world effectiveness of faricimab for nAMD and DME
Robyn Guymer, MBBS, PhD, reported the Voyager study’s preliminary data at the 2024 Angiogenesis, Exudation, and Degeneration conference
Angiogenesis 2024: Highlighting 72-week results from the BALATON and COMINO Phase 3 studies of faricimab in retinal vein occlusion
Ramin Tadayoni, MD, PhD, highlights data from the BALATON and COMINO Phase 3 studies about faricimab
Angiogenesis 2024: Targeting Ang2 and VEGF – Biology, Pharmacokinetics and Latest Clinical Data in nAMD and DME
Dr Jennifer Lim reveals new data on Angiopoietin-2 inhibition and insights on clinical trial design
